Investors Capital Advisory Services’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
BBA
BIT
Investors Capital Advisory Services's ALXN Position: Q2 2016 in Review
Investors Capital Advisory Services increased its Alexion Pharmaceuticals (ALXN) stake by 0.71% in Q2 2016, buying an estimated $1.99K and bringing the position to 1,996 shares worth $233K. The position accounts for 0.04% of the portfolio, ranked #526.
Investors Capital Advisory Services first reported a position in ALXN in Q3 2014 and has held it in 8 quarters since. The position peaked at $466K in Q2 2015. 534 funds tracked by Wall St. Rank hold ALXN as of Q2 2016.
- Investors Capital Advisory Services held 1,996 shares of Alexion Pharmaceuticals worth $233K as of Q2 2016.
- Investors Capital Advisory Services bought 14 Alexion Pharmaceuticals shares in Q2 2016, an estimated $1.99K.
- Alexion Pharmaceuticals made up 0.04% of Investors Capital Advisory Services's portfolio in Q2 2016, its #526 holding.
- Investors Capital Advisory Services first reported a position in Alexion Pharmaceuticals in Q3 2014 and has held it in 8 quarters since.
- Investors Capital Advisory Services's Alexion Pharmaceuticals position peaked at $466K in Q2 2015.
- 534 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2016.
Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.